Development of ELISA for oxidized,malondialdehyde-modified LDL and clinical value

ZHOU Zhuquan,WANG Junjun,FU Li,ZHANG Chunni
2007-01-01
Abstract:Objective To develop enzyme-linked immunosorbent assays (ELISAs) for copper-oxidized (Ox),malondialdehyde-modified (MDA) low-density lipoprotein (LDL) and study their clinical value.Methods Two ELISAs were developed for detecting Ox-LDL and MDA-LDL levels by using self-made polyclonal antibodies,whose precision,recovery and specificity were also tested.Ox-LDL and MDA-LDL levels were determined in patients with coronary heart disease (CHD) and healthy control subjects.Results Both Ox-LDL (178.1±73.8 mg/L vs. 82.7±29.1 mg/L,P<0.01) and MDA-LDL (48.7±25.6 mg/L vs. 39.2±32.9 mg/L,P<0.05) levels were increased in patients with CHD (P<0.05).Ox-LDL and MDA-LDL levels were positively related with total cholesterol, triglyceride and LDL cholesterol,while negatively related with high-density lipoprotein.Conclusions The developed ELISAs are specific,precise,accurate,and useful for clinical application.Both Ox-LDL and MDA-LDL are strong risk factors for atherosclerosis. As a risk factor for predicting atherosclerosis, Ox-LDL is better than MDA-LDL in this study.
What problem does this paper attempt to address?